Interestingly, adoptive transfer of ex vivo-expanded p190BCR-ABL1-specific CD8+ T cells showed encouraging anti-leukemic activity in three patients with Ph+-ALL (137). Here, CD8A is linked to acute lymphoblastic leukemia.